Sitagliptin Phosphate Monohydratum Intermediate CAS 486460-21-3 Puritas >99.0% (HPLC) Factory High Quality Featured Image

Sitagliptin Phosphate Monohydrate Intermedia CAS 486460-21-3 Puritas >99.0% (HPLC)

Description:

Nomen chemicum: 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazinum hydrochloridum

CAS: 486460-21-3

Puritas: >99.0% (HPLC)

Aspectus: Alba et lux Yellow pulveris

Sitagliptin phosphate monohydratorum intermedium (CAS: 654671-77-9) diabete melliti tractatum.

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Supple Sitagliptin Phosphate Monohydratorum intermedia:
Sitagliptin API CAS 486460-32-6
Sitagliptin Phosphate Monohydratum API CAS 654671-77-9
Acidum trifluorophenylaceticum 2,4,5-
Boc-(R)-3-Amino-4-(2,4,5-Trifluoro-Phenyl)-Butyric Acidum CAS 486460-00-8
Sitagliptin Triazole Hydrochloride CAS 762240-92-6
Sitagliptin Phosphate Monohydratum Intermediate CAS 486460-21-3

Chemical Properties:

Nomen chemicum	3-(Trifluoromethyl) -5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride
Synonyma	Sitagliptin Phosphate Monohydratum medium
CAS Number	486460-21-3
CATTUS Number	RF-PI1194
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C6H7F3N4
M. Pondus	192.14
Ferveret	266℃
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Alba ad lux Yellow pulveris
Lepidium sativum	In effusio UV spectri exempli vexillum maximum exhibet minimum in aequalibus aequalibus
Lepidium sativum	HPLC: retentionis tempus Similia
Damnum in Siccatio	<2.00%
Ordinarius Impurities	<1.00%
Puritas / Analysis Methodus	>99.0% (HPLC)
Test Standard	Enterprise Standard
Consuetudinem	Sitagliptin Phosphate Monohydratorum medium (CAS: 654671-77-9)

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;A luce et humore protege.

commoda:

FAQ:

Applicatio:

3-(Trifluoromethyl) -5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazinum hydrochloridum (CAS: 486460-21-3) intermedium est inter Sitagliptin Phosphatis Monohydratorum (. CAS: 654671-77-9) ad tractationem speciei II diabete melliti.Sitagliptin approbatur a FDA ut adiuncto victu et exercitio ad meliorem glycemicam potestatem patientis cum T2DM, sive ut monotherapiam, sive coniunctim cum Metformin vel peroxisome proliferatoractivated receptor-γ agonist (exempli gratia thiazolidinediones) cum unius agentis. glycemic imperium adaequatum non praebet.